Showing 17,001 - 17,020 results of 20,519 for search '"standardization"', query time: 0.10s Refine Results
  1. 17001
  2. 17002

    Tackling ALT-positive neuroblastoma: is it time to redefine risk classification systems? A systematic review with IPD meta-analysis by Marta Avinent-Pérez, Frank Westermann, Samuel Navarro, Amparo López-Carrasco, Rosa Noguera

    Published 2025-02-01
    “…Conclusions: Our study highlights poorer outcomes in ALT-positive neuroblastoma patients, emphasizing the need to integrate TMM status into international risk classification guidelines. Standardizing TMM assessment is key for refining treatment strategies, considering the unique biology of ALT-positive patients.…”
    Get full text
    Article
  3. 17003

    Isolation of Helicobacter pylori from Gastric Biopsy of Dyspeptic Patients in Ghana and In Vitro Preliminary Assessment of the Effect of Dissotis rotundifolia Extract on Its Growth by Michael Buenor Adinortey, Charles Ansah, Cynthia Ayefoumi Adinortey, Ansumana Sandy Bockarie, Martin Tangnaa Morna, Damian H. Amewowor

    Published 2018-01-01
    “…The anti-H. pylori study depicts a statistically lower zone of inhibition for DRE compared to standard drugs [amoxicillin and clarithromycin] (p<0.05), whereas metronidazole showed no zone of inhibition. …”
    Get full text
    Article
  4. 17004

    Comparison of Proliferating Cell Nuclear Antigen Expression in Odontogenic Keratocyst and Ameloblastoma: An Immunohistochemical Study by Hiroshi Takahashi, Shuichi Fujita, Shigeru Yamabe, Takeshi Moriishi, Haruo Okabe, Yoshifumi Tajima, Akio Mizuno

    Published 1998-01-01
    “…The percentage of PCNA-positive cells determined by point counting was significantly lower in the ameloblastomas (mean 9.4%, standard deviation (SD) 11.0) than in odontogenic keratocysts (mean 29.9%, SD 24.0). …”
    Get full text
    Article
  5. 17005

    A novel adaptive FOCV algorithm with robust IMRAC control for sustainable and high-efficiency MPPT in standalone PV systems: experimental validation and performance assessment by Hamid Belghiti, Khalid Kandoussi, Ambe Harrison, Fatima Zahra Moustaine, Rabie El Otmani, El Mostafa Sadek, Mohit Bajaj, Shir Ahmad Dost Mohammadi

    Published 2024-12-01
    “…Comparative analysis with state-of-the-art MPPT controllers, including P&O-PI, InC-SMC, FLC, and VS P&O Backstepping, demonstrates superior tracking efficiency exceeding 99.49% under EN 50,530 standard test conditions. The system also maintains exceptional performance with minimal efficiency loss across a wide range of temperature and irradiance variations. …”
    Get full text
    Article
  6. 17006

    Analysis of GAA Junction Less NS FET Towards Analog and RF Applications at 30 nm Regime by Asisa Kumar Panigrahy, Sudheer Hanumanthakari, Shridhar B. Devamane, Shruti Bhargava Choubey, M. Prasad, D. Somasundaram, N. Kumareshan, N. Arun Vignesh, Gnanasaravanan Subramaniam, Durga Prakash M, Raghunandan Swain

    Published 2024-01-01
    “…This research focuses on a quantum model created using an entirely novel nanosheet FET. The standard model describes the performance of a Gate-all-around (GAA) Junction-less (JL) nanosheet device with a gate dielectric of SiO<sub>2</sub> and HfO<sub>2</sub>, each having a thickness of 1 nm. …”
    Get full text
    Article
  7. 17007

    Hemorrhagic syndrome at liver cirrhosis by I. A. Kurkina, O. S. Volkova, M. V. Mayevskaya, V. T. Ivashkin

    Published 2012-11-01
    “…Laboratory diagnostics of disorders in «hemostasisfibrinolysis» system in patients with the LC underwent essential changes at the last decade. Standard complex tests for hemostasis lose their diagnostic value in this group of patients. …”
    Get full text
    Article
  8. 17008

    After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia by Mario Delia, Paola Carluccio, Anna Mestice, Roberta Frappampina, Francesco Albano, Giorgina Specchia, Pellegrino Musto

    Published 2020-01-01
    “…We studied 39 AML younger patients (<65 years), all treated with standard induction chemotherapy. ORR (complete remission (CR)+CR with incomplete hematologic recovery (CRi)) was documented in 21 out of 39 patients (54%); two partial responder patients were also recorded. …”
    Get full text
    Article
  9. 17009

    An electrolyte-gated transistor for the monitoring of a CRISPR/Cas activity by Pierre Guermonprez, Le Tu Anh, Louis Renaud, Pierre Nioche, Eric Krejci, Aurélie Alleaume-Butaux, Nicolas Battaglini, Vu Thi Thu, Sébastien Sanaur, Benoît Piro

    Published 2025-05-01
    “…Reverse transcriptase-polymerase chain reaction (RT-PCR) remains the gold standard, but clustered regularly interspaced short palindromic repeats linked to a Cas endoribonuclease particle (CRISPR/Cas) have recently revolutionized the recognition step of two RNAs, i.e. the CRISPR-RNA (crRNA) and the target, providing a much better selectivity compared to the naked hybridization on which RT-PCR is based. …”
    Get full text
    Article
  10. 17010

    Real‐world efficacy of transfusion with liberal or restrictive strategy in traumatic brain injury by Liang‐Wen Cui, Nian Liu, Chao Yu, Ming Fang, Rui Huang, Cheng Zhang, Min Shao

    Published 2025-01-01
    “…The imbalance induced by informative censoring was adjusted by inverse probability weighting. The standardized, weighted pooled logistic regression with 500 bootstrap resampling was used to estimate the cumulative risk difference and 95% confidence interval (CI). …”
    Get full text
    Article
  11. 17011

    An extensive review on implantable antennas for biomedical applications: Health considerations, geometries, fabrication techniques, and challenges by Mosab Jasim, Ahmed Jamal Abdullah Al-Gburi, Mehwish Hanif, Zaheer Ahmed Dayo, Mohd Muzafar Ismail, Zahriladha Zakaria

    Published 2025-01-01
    “…Meeting these stringent standards is essential to ensure that IMDs operate safely and effectively within the human body over extended periods. …”
    Get full text
    Article
  12. 17012
  13. 17013

    Clonal dissemination of an NDM-2-producing Acinetobacter baumannii ST103 clone resulting in an outbreak in an intensive care unit of a Lebanese tertiary care hospital by Tania Nawfal Dagher, Linda Hadjadj, Fadi Bittar, Fadi Fenianos, Elias Abdo, Jean-Marc Rolain, Charbel Al-Bayssari

    Published 2025-01-01
    “…Antibiotic susceptibility testing was carried out using the disk diffusion method and carbapenemase-encoding genes were searched for using standard polymerase chain reaction. Epidemiological relatedness was studied using multilocus sequence typing. …”
    Get full text
    Article
  14. 17014

    Impaired Growth during Childhood in Patients with Primary Ciliary Dyskinesia by Tamara Svobodová, Jana Djakow, Daniela Zemková, Adam Cipra, Petr Pohunek, Jan Lebl

    Published 2013-01-01
    “…BMI did not differ from population standards, which suggests that nutritional deficits are not the cause of growth delay. …”
    Get full text
    Article
  15. 17015

    Efficient Dual Cas9 Nickase Correction of a Prevalent Pathogenic LAMB3 Variant for Junctional Epidermolysis Bullosa by Alex du Rand, John Hunt, Daniel Verdon, Ben Buttle, P. Rod Dunbar, Diana Purvis, Vaughan Feisst, Hilary Sheppard

    Published 2025-05-01
    “…Targeting a hotspot pathogenic variant (c.1903C>T, p.R635∗), we report perfect correction efficiencies of up to 54% based on standard next-generation sequencing. Using a high-fidelity Cas9 nuclease, we also report perfect repair of up to 74% when using a small-molecule modulator of DNA repair. …”
    Get full text
    Article
  16. 17016

    CYP2C19 Genotype‐Guided Antiplatelet Therapy and Clinical Outcomes in Patients Undergoing a Neurointerventional Procedure by Kayla R. Tunehag, Ashton F. Pearce, Layna P. Fox, George A. Stouffer, Sten Solander, Craig R. Lee

    Published 2025-01-01
    “…ABSTRACT In neurovascular settings, including treatment and prevention of ischemic stroke and prevention of thromboembolic complications after percutaneous neurointerventional procedures, dual antiplatelet therapy with a P2Y12 inhibitor and aspirin is the standard of care. Clopidogrel remains the most commonly prescribed P2Y12 inhibitor for neurovascular indications. …”
    Get full text
    Article
  17. 17017

    Mitigation of Mycotoxin Content by a Single-Screw Extruder in Triticale (<i>x Triticosecale</i> Wittmack) by Breda Jakovac-Strajn, Janja Babič, Lato Pezo, Vojislav Banjac, Radmilo Čolović, Jovana Kos, Jelena Miljanić, Elizabet Janić Hajnal

    Published 2025-01-01
    “…The temperature at the end plate of the extruder ranged between 97.6 and 141 °C, the absolute pressure was from 0.10 to 0.42 MPa, the mean retention time of material in the barrel was between 16 and 35 s, and the specific energy consumption was from 91.5 to 186.6 Wh/kg. According to the standard score, the optimum parameters for the reduction of the content of analysed mycotoxins were <i>M</i> = 24 g/100 g, <i>FR</i> = 25 kg/h, <i>SS</i> = 480 RPM, with a reduction of 3.80, 60.7, 61.5, 86.5, 47.7, and 55.9% for DON, 3-AcDON, 15-AcDON, HT-2, TEN, and AME, respectively. …”
    Get full text
    Article
  18. 17018

    Fluorescence Lifetime Imaging of NAD(P)H in Patients’ Lymphocytes: Evaluation of Efficacy of Immunotherapy by Diana V. Yuzhakova, Daria A. Sachkova, Anna V. Izosimova, Konstantin S. Yashin, Gaukhar M. Yusubalieva, Vladimir P. Baklaushev, Artem M. Mozherov, Vladislav I. Shcheslavskiy, Marina V. Shirmanova

    Published 2025-01-01
    “…The FLIM data correlated well with the standard assays of immunotherapy drug response in vitro, including morphological changes, the T-cells activation marker CD69, and the tumor cell proliferation index Ki67. …”
    Get full text
    Article
  19. 17019

    Pediatric pancreatic acinar cell carcinoma with a non-canonical BRAF-KMT2C fusion and a classic SND1-BRAF fusion: a case report and literature review by Yaqin Wang, Jiasi Zhang, Dimin Nie, Ai Zhang, Qun Hu, Aiguo Liu

    Published 2025-01-01
    “…Its clinical presentation is often atypical, and standardized treatment guidelines are currently unavailable. …”
    Get full text
    Article
  20. 17020

    Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan by Wei-Chen Tai, Chien-Hua Chiu, Chih-Ming Liang, Kuo-Chin Chang, Chung-Mou Kuo, Yi-Chun Chiu, Keng-Liang Wu, Ming-Luen Hu, Yeh-Pin Chou, Shue-Shian Chiou, King-Wah Chiu, Chung-Huang Kuo, Tsung-Hui Hu, Ming-Tsung Lin, Seng-Kee Chuah

    Published 2013-01-01
    “…A total of 200 patients who failed H. pylori eradication using the standard triple therapy were prescribed with either a 10-day (EAL-10) or a 14-day (EAL-14) levofloxacin-containing triple therapy group (levofloxacin 500 mg once daily, amoxicillin 1 g twice daily, and esomeprazole 40 mg twice daily). …”
    Get full text
    Article